Assembly Biosciences develops antiviral medicines for serious viral diseases, including genital herpes and hepatitis. It last closed at $22.19 on Nov 20, down 1.38% on the day. The next earnings report for ASMB is expected around Thu, Mar 18, 2027, after the close. For the quarter ended Sep 2026, ASMB reported EPS of -$0.93 on revenue of $3.0M, with revenue down 72.6% from a year ago. Over its last 8 reports the stock moved an average of 4.6% the session after earnings. Over the last 12 months ASMB insiders bought $0 of stock on the open market and sold $252K, according to SEC Form 4 filings.
AI Auto Pilots
Is ASMB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ASMB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ASMBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ASMB · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend
The stock is 6% above its 20 day and 0% above its 50 day average. It is 21% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 53). The nearest support is the 50 day average at $22.17, and the nearest resistance the Pivot at $22.28.
Short trendBullish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$39.7052 week high+78.9%
$26.74200 day average+20.5%
$25.88100 day average+16.6%
$22.70Pivot R1+2.3%
$22.69Swing high (Nov 11)+2.3%
$22.28Pivot+0.4%
$22.19Last close
$22.1750 day average−0.1%
$21.80Swing low (Oct 6)−1.8%
$21.78Pivot S1−1.8%
$20.9520 day average−5.6%
$19.2052 week low−13.5%
Indicators
RSI (14)
53.38
Middle of its range
Neutral
MACD
0.00
Above its signal line
Bullish
Stochastic
73.5
Middle of its range
Neutral
ADX (14)
22.0
Weak trend
Williams %R
-30.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
111.4
Oversold below −100, overbought above 100
Overbought
Rate of change
+8.7%
Change over 10 sessions
Bullish
ATR (14)
$1.25
Typical daily range, 5.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 14.9%/day
Key levels
$39.7052 week high+78.9%
$26.74200 day average+20.5%
$25.88100 day average+16.6%
$22.70Pivot R1+2.3%
$22.69Swing high (Nov 11)+2.3%
$22.28Pivot+0.4%
$22.19Last close
$22.1750 day average−0.1%
$21.80Swing low (Oct 6)−1.8%
$21.78Pivot S1−1.8%
$20.9520 day average−5.6%
$19.2052 week low−13.5%
Indicators
RSI (14)
42.75
Middle of its range
Neutral
MACD
-1.96
Below its signal line
Bearish
Stochastic
11.5
Near the bottom of its range
Oversold
ADX (14)
17.2
No clear trend
Williams %R
-83.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-63.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−25.5%
Change over 10 sessions
Bearish
ATR (14)
$3.30
Typical daily range, 14.9% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for ASMB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ASMB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ASMB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ASMBHow many large options trades hit ASMB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ASMB in the last 90 days.
From SEC Form 4 filings by ASMB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASMB is in one of them and how their past ASMB trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Assembly Biosciences
Assembly Biosciences is a biotechnology company based in South San Francisco, California, that develops antiviral medicines for people with serious viral diseases. Its experimental treatments target genital herpes, hepatitis delta, hepatitis B and herpesviruses that can affect transplant patients. Gilead Sciences has licensed its genital herpes program, and the company is seeking partners for its hepatitis B candidate. Its other programs remain in clinical testing or early research.